What you should know about Remdesivir potential drug for COVID-19

AM Show

ST. LOUIS – Remdesivir, the first major drug approved by the FDA to help treat COVID-19 patients underwent its first round of trials; 163,000 COVID-19 patients were part of this trial.

Dr. Alex Lacasse an infectious disease specialist at SSM Health St. Mary’s joined Fox 2 via Skype to discuss the findings in this first trial, and how the drug works on COVID-19.

For more information visit: www.SSMhealth.com

FOX 2 Newsletters

Sign up for a newsletter from FOX 2 to get updates about news and weather. We offer daily headlines, breaking news, severe weather, and forecast emails.

Popular

Latest News

More News